These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8399575)

  • 1. Insulin prescription, glycemic control, and diabetic complications in diabetics treated by continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Allouache M
    Perit Dial Int; 1993; 13 Suppl 2():S232-5. PubMed ID: 8399575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 3. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
    Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
    Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of blood glucose in diabetic dialysis patients].
    Hori K; Fujimi S
    Nihon Rinsho; 1992 Jan; 50 Suppl():192-6. PubMed ID: 1578677
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
    Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
    Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRD.
    Flynn JT; Kershaw DB; Sedman AB; Smoyer WE; Bunchman TE
    Adv Perit Dial; 1998; 14():265-8. PubMed ID: 10649738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
    Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin dependent diabetics?
    Rottembourg J; de Groc F; Poignet JL; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():215-20. PubMed ID: 6348737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous ambulatory peritoneal dialysis in terminal renal-insufficiency diabetics].
    Kuhlmann H; Thomae U; Herrmann M; Eberhard K
    Med Klin; 1981 Mar; 76(6):169-76. PubMed ID: 7015094
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic ambulatory peritoneal dialysis.
    Harrington JT
    N Engl J Med; 1982 Mar; 306(11):670-1. PubMed ID: 7035948
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous ambulatory peritoneal dialysis in diabetic patients.
    Scarpioni LL; Ballocchi S; Castelli A; Cecchettin M; Poisetti PG
    Contrib Nephrol; 1990; 84():60-74. PubMed ID: 2261783
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialyzing the diabetic - a second look.
    Roxe DM
    Int J Artif Organs; 1982 Sep; 5(5):284-6. PubMed ID: 6757148
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy.
    Grefberg N; Danielson BG; Nilsson P
    Acta Med Scand; 1984; 215(5):427-34. PubMed ID: 6377827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for glucose control in diabetics on CAPD.
    Passadakis P; Thodis E; Vargemezis V; Oreopoulos G
    Int J Artif Organs; 1999 Oct; 22(10):657-64. PubMed ID: 10585128
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.